United States President Donald Trump announced on Tuesday that he intends to apply a progressive tariff on imported medicines, which could reach 250% within a year and a half. According to him, the initiative aims to pressure pharmaceutical companies to maintain or transfer their operations into the US territory
“Initially, let’s put a low rate on pharmaceutical products, but in a year, a year and a half, will rise to 150% and then to 250% because we want pharmaceutical products to be manufactured in our country,” Trump said in an interview with CNBC.
To date, there are no published official measures. The proposal is part of a wider strategy of Trump to press the sector and reduce drug prices in the country, which, according to him, are far superior to those practiced in other industrialized nations.
Last week, the White House sent letters to 17 pharmacists requiring the reduction of prices charged in the United States. Companies have until September 29 to present formal agreements. Otherwise, they may face this new sanction.
In July, Trump had promised that he would reduce the price of medicines by up to 1,500%.
Laura Basilio under supervision of Thiago San.
